Echo-guided left ventricular assist device speed optimisation for exercise maximisation.


Journal

Heart (British Cardiac Society)
ISSN: 1468-201X
Titre abrégé: Heart
Pays: England
ID NLM: 9602087

Informations de publication

Date de publication:
10 06 2022
Historique:
received: 26 10 2021
accepted: 24 02 2022
pubmed: 23 3 2022
medline: 15 6 2022
entrez: 22 3 2022
Statut: epublish

Résumé

Current generation left ventricular assist devices (LVADs) operate with a fixed rotation speed and no automated speed adjustment function. This study evaluates the concept of physiological pump speed optimisation based on aortic valve opening (AVO) imaging during a cardiopulmonary exercise test (CPET). This prospective crossover study (NCT05063006) enrolled patients with implanted third-generation LVADs with hydrodynamic bearing. After resting speed optimisation, patients were randomised to a fixed-modified speed or modified-fixed speed CPET sequence. Fixed speed CPET maintained baseline pump settings. During the modified speed CPET, the LVAD speed was continuously altered to preserve periodic AVO. We included 22 patients, the mean age was 58.4±7 years, 4.5% were women and 54.5% had ischaemic cardiomyopathy. Exertional AVO assessment was feasible in all subjects. Maintaining periodic AVO allowed to safely raise the pump speed from 2900 (IQR 2640-3000) to 3440 revolutions per minute (RPM) (IQR 3100-3700; p<0.001). As a result, peak oxygen consumption increased from 11.1±2.4 to 12.8±2.8 mL/kg/min (p<0.001) and maximum workload from 1.1 (IQR 0.9-1.5) to 1.2 W/kg (IQR 0.9-1.7; p=0.028). The Borg scale exertion level decreased from 15.2±1.5 to 13.5±1.2 (p=0.005). Transthoracic AVO imaging is possible during CPETs in patients with LVAD. Dynamic echo-guided pump speed adjustment based on the AVO improves exercise tolerance and augments peak oxygen consumption and maximum workload.

Identifiants

pubmed: 35314453
pii: heartjnl-2021-320495
doi: 10.1136/heartjnl-2021-320495
pmc: PMC9209671
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1055-1062

Commentaires et corrections

Type : CommentIn

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Circ Heart Fail. 2021 Jan;14(1):e007448
pubmed: 33464953
J Ultrasound Med. 2012 Nov;31(11):1795-802
pubmed: 23091251
Eur J Heart Fail. 2012 Jun;14(6):613-20
pubmed: 22505397
Eur J Heart Fail. 2014 Apr;16(4):403-8
pubmed: 24464845
JACC Heart Fail. 2016 Mar;4(3):208-17
pubmed: 26746378
J Card Fail. 2015 Oct;21(10):785-91
pubmed: 26117282
J Heart Lung Transplant. 2015 Apr;34(4):489-96
pubmed: 25577562
J Thorac Dis. 2018 Jun;10(Suppl 15):S1802-S1810
pubmed: 30034856
Physiol Meas. 2013 Jan;34(1):R1-27
pubmed: 23242235
Artif Organs. 2019 Mar;43(3):222-228
pubmed: 30155903
Eur J Cardiothorac Surg. 2014 Sep;46(3):356-60; discussion 360
pubmed: 24499877
Artif Organs. 2019 May;43(5):458-466
pubmed: 30375659
Ann Biomed Eng. 2016 Aug;44(8):2377-2387
pubmed: 26833037
JACC Heart Fail. 2020 Apr;8(4):291-301
pubmed: 32035893
J Heart Lung Transplant. 2015 Aug;34(8):1005-16
pubmed: 25682553
J Heart Lung Transplant. 2017 Jan;36(1):36-41
pubmed: 27522486
Ann Thorac Surg. 2020 Mar;109(3):649-660
pubmed: 32115073
Comput Biol Med. 2015 Nov 1;66:135-43
pubmed: 26409226
Artif Organs. 2014 Apr;38(4):290-7
pubmed: 24102321
IEEE Trans Biomed Eng. 2016 Jun;63(6):1201-7
pubmed: 26461795
ASAIO J. 2015 May-Jun;61(3):307-12
pubmed: 25485566
J Heart Lung Transplant. 2021 Feb;40(2):128-137
pubmed: 33281029
Eur J Cardiothorac Surg. 2016 Oct;50(4):752-757
pubmed: 27174552
PLoS One. 2020 Mar 18;15(3):e0229688
pubmed: 32187193
JACC Heart Fail. 2015 Jul;3(7):554-564
pubmed: 26071617
J Am Coll Cardiol. 2012 Oct 30;60(18):1764-75
pubmed: 23040584
Circ Heart Fail. 2011 Sep;4(5):554-60
pubmed: 21765126
Artif Organs. 2020 Mar;44(3):239-247
pubmed: 31519043

Auteurs

Maciej Stapor (M)

Department of Interventional Cardiology, John Paul II Hospital, Krakow, Malopolska, Poland m.stapor@szpitaljp2.krakow.pl.

Adam Pilat (A)

Department of Automatic Control and Robotics, AGH University of Science and Technology, Krakow, Poland.

Andrzej Gackowski (A)

Department of Coronary Disease and Heart Failure, Jagiellonian University Medical College, Faculty of Medicine, Institute of Cardiology, Krakow, Poland.

Agnieszka Misiuda (A)

Noninvasive Cardiovascular Laboratory, John Paul II Hospital, Krakow, Poland.

Izabela Gorkiewicz-Kot (I)

Department of Cardiovascular Surgery and Transplantology, John Paul II Hospital, Krakow, Poland.

Michal Kaleta (M)

Department of Cardiovascular Surgery and Transplantology, John Paul II Hospital, Krakow, Poland.

Pawel Kleczynski (P)

Department of Interventional Cardiology, Jagiellonian University Medical College, Faculty of Medicine, Institute of Cardiology, Krakow, Poland.

Krzysztof Zmudka (K)

Department of Interventional Cardiology, Jagiellonian University Medical College, Faculty of Medicine, Institute of Cardiology, Krakow, Poland.

Jacek Legutko (J)

Department of Interventional Cardiology, Jagiellonian University Medical College, Faculty of Medicine, Institute of Cardiology, Krakow, Poland.

Boguslaw Kapelak (B)

Department of Cardiovascular Surgery and Transplantology, Jagiellonian University Medical College, Faculty of Medicine, Institute of Cardiology, Krakow, Poland.

Karol Wierzbicki (K)

Department of Cardiovascular Surgery and Transplantology, Jagiellonian University Medical College, Faculty of Medicine, Institute of Cardiology, Krakow, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH